Parent
Compound |
Analytes |
Species |
Matrix |
LLOQ- ULOQ |
Validated Sample Vol. (mL) |
Method |
Anti-
coagulant |
| Abacavir |
Abacavir |
Human |
P |
2.50- 5,000 ng/mL |
0.050 |
LC- MS/MS |
2 |
|
Lamivudine |
Human |
P |
2.50- 5,000 ng/mL |
0.050 |
LC- MS/MS |
2 |
| |
| Amphetamine |
Amphetamine |
Human |
P |
0.100- 50.0 ng/mL |
0.250 |
LC- MS/MS |
5 |
|
Methamphetamine |
Human |
P |
0.100- 50.0 ng/mL |
0.250 |
LC- MS/MS |
5 |
| |
| Amrubicin |
Amrubicin |
Human |
P |
2.00- 2,000 ng/mL |
0.200 |
LC- MS/MS |
2 |
|
Amrubicinol |
Human |
P |
2.00- 400 ng/mL |
0.200 |
LC- MS/MS |
2 |
| |
| Atorvastatin |
Atorvastatin |
Human |
P |
0.250- 100 ng/mL |
0.100 |
LC- MS/MS |
5 |
|
Ortho- hydroxyatorvastatin |
Human |
P |
0.250- 100 ng/mL |
0.100 |
LC- MS/MS |
5 |
|
Para- hydroxyatorvastatin |
Human |
P |
0.250- 100 ng/mL |
0.100 |
LC- MS/MS |
5 |
| |
| Caffeine |
Caffeine |
Human |
P |
25.0- 20,000 ng/mL |
0.100 |
LC- MS/MS |
2, 5 |
|
Paraxanthine |
Human |
P |
25.0- 20,000 ng/mL |
0.100 |
LC- MS/MS |
2 |
| |
| Cortisol |
Cortisol |
Human |
U |
3.00- 200 ng/mL |
0.050 |
LC- MS/MS |
N |
|
6-beta-hydroxycortisol |
Human |
U |
1.00- 200 ng/mL |
0.050 |
LC- MS/MS |
N |
| |
| Cortisol |
Cortisol |
Human |
U |
3.00- 200 ng/mL |
0.025 |
LC- MS/MS |
N |
|
6-beta-hydroxycortisol |
Human |
U |
50.0- 10,000 ng/mL |
0.025 |
LC- MS/MS |
N |
| |
| Desipramine |
Desipramine |
Human |
P |
0.250- 100 ng/mL |
0.100 |
LC- MS/MS |
2 |
|
2-Hydroxydesipramine |
Human |
P |
0.250- 100 ng/mL |
0.100 |
LC- MS/MS |
2 |
| |
| Dextromethorphan |
Dextromethorphan |
Human |
P |
0.100- 100 ng/mL |
0.050 |
LC- MS/MS |
2 |
|
Dextrorphan |
Human |
P |
5.00- 2,500 ng/mL |
0.050 |
LC- MS/MS |
2 |
| |
| Dextromethorphan |
Dextromethorphan |
Human |
P |
0.100- 25.0 ng/mL |
0.200 |
LC- MS/MS |
2 |
|
Dextrophan |
Human |
P |
5.00- 1,250 ng/mL |
0.200 |
LC- MS/MS |
2 |
| |
| Dextromethorphan |
Dextromethorphan |
Human |
P |
0.0100- 10.0 ng/mL |
0.100 |
LC- MS/MS |
6 |
|
Dextrophan |
Human |
P |
0.300- 300 ng/mL |
0.100 |
LC- MS/MS |
6 |
| |
| Dextromethorphan |
Dextromethorphan |
Human |
P |
5.00- 1,000 ng/mL |
0.200 |
LC- MS/MS |
2 |
|
Dextrophan |
Human |
P |
5.00- 1,000 ng/mL |
0.200 |
LC- MS/MS |
2 |
| |
| Diazepam |
Diazepam |
Human |
P |
1.00- 500 ng/mL |
0.100 |
LC- MS/MS |
2 |
|
Desmethyl Diazepam |
Human |
P |
1.00- 500 ng/mL |
0.100 |
LC- MS/MS |
2 |
| |
| Diclofenac |
Diclofenac |
Human |
P |
5.00- 2,500 ng/mL |
0.050 |
LC- MS/MS |
2 |
|
4- Hydroxydiclofenac |
Human |
P |
5.00- 2,500 ng/mL |
0.050 |
LC- MS/MS |
2 |
| |
| Ethambutol |
Ethambutol |
Human |
P |
10.0- 5,000 ng/mL |
0.050 |
LC- MS/MS |
2 |
|
Pyrazinamide |
Human |
P |
50.0- 25,000 ng/mL |
0.050 |
LC- MS/MS |
2 |
| |
| Ethinyl Estradiol |
Ethinyl Estradiol |
Human |
P |
2.50- 500 pg/mL |
0.500 |
LC- MS/MS |
2 |
|
Levonorgestrel |
Human |
P |
50.0- 10,000 pg/mL |
0.500 |
LC- MS/MS |
2 |
| |
| Ethinyl Estradiol |
Ethinyl Estradiol |
Human |
P |
7.50- 500 pg/mL |
0.500 |
LC- MS/MS |
2 |
|
Levonorgestrel |
Human |
P |
150- 10,000 pg/mL |
0.500 |
LC- MS/MS |
2 |
| |
| Fluoxetine |
Fluoxetine |
Human |
P |
0.500- 250 ng/mL |
0.100 |
LC- MS/MS |
2, 6 |
|
Norfluoxetine |
Human |
P |
0.500- 250 ng/mL |
0.100 |
LC- MS/MS |
2, 6 |
| |
| Gemcitabine |
Gemcitabine |
Human |
P |
50.0- 50,000 ng/mL |
0.050 |
LC- MS/MS |
2, 6 |
|
2'difluoro-2', 2'-deoxyuridine (dFdU) |
Human |
P |
50.0- 50,000 ng/mL |
0.050 |
LC- MS/MS |
2, 6 |
| |
| Hydrocodone |
Hydrocodone |
Human |
P |
0.100- 100 ng/mL |
0.100 |
LC- MS/MS |
2 |
|
Hydromorphone |
Human |
P |
0.100- 100 ng/mL |
0.100 |
LC- MS/MS |
2 |
|
Norhydrocodone |
Human |
P |
0.100- 100 ng/mL |
0.100 |
LC- MS/MS |
2 |
| |
| Ibuprofen |
R-Ibuprofen |
Human |
P |
100- 20,000 ng/mL |
0.500 |
LC- FL |
6 |
|
S-Ibuprofen |
Human |
P |
100- 20,000 ng/mL |
0.500 |
LC- FL |
6 |
| |
| Ketamine |
Ketamine |
Human |
P |
0.500- 500 ng/mL |
0.200 |
LC- MS/MS |
2 |
|
Norketamine |
Human |
P |
0.500- 500 ng/mL |
0.200 |
LC- MS/MS |
2 |
| |
| Ketoprofen |
R-Ketoprofen |
Human |
P |
0.500- 1,000 ng/mL |
0.100 |
LC- MS/MS |
6 |
|
S-Ketoprofen |
Human |
P |
0.500- 1,000 ng/mL |
0.100 |
LC- MS/MS |
6 |
| |
| Lidocaine |
Lidocaine |
Human |
P |
0.500- 200 ng/mL |
0.050 |
LC- MS/MS |
2 |
|
Prilocaine |
Human |
P |
0.500- 200 ng/mL |
0.050 |
LC- MS/MS |
2 |
| |
| Loratadine |
Loratadine |
Human |
P |
10.0- 10,000 pg/mL |
0.200 |
LC- MS/MS |
6 |
|
Descarboethoxy Loratadine |
Human |
P |
25.0- 25,000 pg/mL |
0.200 |
LC- MS/MS |
6 |
| |
| Losartan |
Losartan |
Human |
P |
2.00- 1,000 ng/mL |
0.100 |
LC- MS/MS |
5 |
|
Losartan Carboxylic Acid |
Human |
P |
2.00- 1,000 ng/mL |
0.100 |
LC- MS/MS |
5 |
|
Hydrochlorothiazide |
Human |
P |
1.00- 1,000 ng/mL |
0.100 |
LC- MS/MS |
5 |
| |
| Lovastatin |
Lovastatin |
Human |
P |
0.100- 50.0 ng/mL |
0.500 |
LC- MS/MS |
2 |
|
Lovastatin Acid |
Human |
P |
0.100- 50.0 ng/mL |
0.500 |
LC- MS/MS |
2 |
| |
| Morphine |
Morphine |
Human |
P |
0.500- 50.0 ng/mL |
0.250 |
LC- MS/MS |
3, 5, 6 |
|
Morphine-6-β-Glucuronide |
Human |
P |
1.00- 100 ng/mL |
0.250 |
LC- MS/MS |
3, 5, 6 |
|
Morphine-3-β-Glucuronide |
Human |
P |
10.0- 1,000 ng/mL |
0.250 |
LC- MS/MS |
3, 5, 6 |
| |
| Methotrexate |
Methotrexate |
Human |
P |
1.00- 250 ng/mL |
0.050 |
LC- MS/MS |
5 |
|
7-Hydroxymethotrexate |
Human |
P |
1.00- 250 ng/mL |
0.050 |
LC- MS/MS |
5 |
| |
| Methylphenidate |
d-threo-Methylphenidate |
Human |
P |
0.250- 50.0 ng/mL |
0.500 |
LC- MS/MS |
2 |
|
l-threo-Methylphenidate |
Human |
P |
0.250- 50.0 ng/mL |
0.500 |
LC- MS/MS |
2 |
| |
| Midazolam |
Midazolam |
Human |
P |
0.100- 100 ng/mL |
0.200 |
LC- MS/MS |
2, 5, 6 |
|
1'-Hydroxymidazolam |
Human |
P |
0.100- 100 ng/mL |
0.200 |
LC- MS/MS |
2, 5, 6 |
| |
| Midazolam |
Midazolam |
Human |
P |
0.100- 100 ng/mL |
0.400 |
LC- MS/MS |
2, 6 |
|
1'-Hydroxymidazolam |
Human |
P |
0.100- 100 ng/mL |
0.400 |
LC- MS/MS |
2, 6 |
|
4-Hydroxymidazolam |
Human |
P |
0.100- 100 ng/mL |
0.400 |
LC- MS/MS |
2, 6 |
| |
| Modafinil (R-) |
R-Modafinil |
Human |
P |
0.200- 50.0 µg/mL |
0.200 |
LC- UV |
5 |
|
R-Modafinil acid |
Human |
P |
0.200- 50.0 µg/mL |
0.200 |
LC- UV |
5 |
|
Modafinil sulfone |
Human |
P |
0.200- 50.0 µg/mL |
0.200 |
LC- UV |
5 |
| |
| Morphine |
Morphine |
Human |
P/S |
0.500- 50.0 ng/mL |
0.250 |
LC- MS/MS |
6 |
|
Morphine-3-B-d-glucuronide |
Human |
P/S |
10.0- 1,000 ng/mL |
0.250 |
LC- MS/MS |
6 |
|
Morphine-6-B-d-glucuronide, |
|
|
|
|
|
|
|
dihydrate |
Human |
P/S |
1.00- 100 ng/mL |
0.250 |
LC- MS/MS |
6 |
| |
| Morphine |
Morphine |
Human |
S |
0.500- 50.0 ng/mL |
0.250 |
LC- MS/MS |
N |
|
Morphine-3-B-d-glucuronide |
Human |
S |
1.00- 100 ng/mL |
0.250 |
LC- MS/MS |
N |
|
Morphine-6-B-d-glucuronide |
Human |
S |
1.00- 100 ng/mL |
0.250 |
LC- MS/MS |
N |
| |
| Naltrexone |
Naltrexone |
Human |
P |
0.250- 100 ng/mL |
1.000 |
LC- MS/MS |
6 |
|
Naltrexol, beta |
Human |
P |
0.250- 100 ng/mL |
1.000 |
LC- MS/MS |
6 |
| |
| Nicotine |
Nicotine |
Human |
P |
1.00- 200 ng/mL |
0.250 |
LC- MS/MS |
2, 1 |
|
Cotinine |
Human |
P |
10.0- 2,000 ng/mL |
0.250 |
LC- MS/MS |
2 |
| |
| Nitrosamine |
Nitrosamine, free |
Human |
U |
10.0- 2,500 pg/mL |
2.000 |
LC- MS/MS |
N |
|
Nitrosamine, total |
Human |
U |
10.0- 2,500 pg/mL |
2.000 |
LC- MS/MS |
N |
| |
| NNAL |
NNAL, free |
Human |
P |
5.00- 1,000 pg/mL |
0.500 |
LC- MS/MS |
2 |
|
NNAL, total |
Human |
P |
5.00- 1,000 pg/mL |
0.500 |
LC- MS/MS |
2 |
| |
| NNAL |
NNAL, free |
Human |
U |
10.0- 2,500 pg/mL |
2.000 |
LC- MS/MS |
N |
|
NNAL, total |
Human |
U |
10.0- 2,500 pg/mL |
2.000 |
LC- MS/MS |
N |
| |
| Omeprazole |
Omeprazole |
Human |
P |
2.50- 2,500 ng/mL |
0.050 |
LC- MS/MS |
6 |
|
5-Hydroxyomeprazole |
Human |
P |
2.50- 2,500 ng/mL |
0.050 |
LC- MS/MS |
6 |
| |
| Omeprazole |
Omeprazole |
Human |
P |
0.500- 1,000 ng/mL |
0.050 |
LC- MS/MS |
2 |
|
5-Hydroxyomeprazole |
Human |
P |
0.500- 1,000 ng/mL |
0.050 |
LC- MS/MS |
2 |
| |
| Oxycodone |
Oxycodone |
Human |
P |
0.100- 50.0 ng/mL |
0.400 |
LC- MS/MS |
2 |
|
Noroxycodone |
Human |
P |
0.100- 50.0 ng/mL |
0.400 |
LC- MS/MS |
2 |
|
Oxymorphone |
Human |
P |
0.100- 50.0 ng/mL |
0.400 |
LC- MS/MS |
2 |
| |
| Selegiline |
Selegiline |
Human |
P |
0.100- 200 ng/mL |
0.250 |
LC- MS/MS |
6 |
|
Desmethyl Selegiline |
Human |
P |
0.100- 200 ng/mL |
0.250 |
LC- MS/MS |
6 |
|
Amphetamine |
Human |
P |
0.500- 20.0 ng/mL |
0.250 |
LC- MS/MS |
6 |
|
Methamphetamine |
Human |
P |
0.500- 20.0 ng/mL |
0.250 |
LC- MS/MS |
6 |
| |
| Sertraline |
Sertraline |
Human |
P |
0.250- 100 ng/mL |
0.250 |
LC- MS/MS |
6 |
|
Desmethyl Sertraline |
Human |
P |
0.500- 100 ng/mL |
0.250 |
LC- MS/MS |
6 |
| |
| Sildenafil |
Sildenafil |
Human |
P |
1.00- 500 ng/mL |
0.100 |
LC- MS/MS |
5, 6 |
|
Desmethyl Sildenafil |
Human |
P |
1.00- 500 ng/mL |
0.100 |
LC- MS/MS |
5, 6 |
| |
| Sildenafil |
Sildenafil |
Human |
UF |
0.200- 100 ng/mL |
0.100 |
LC- MS/MS |
5 |
|
Desmethyl Sildenafil |
Human |
UF |
0.200- 100 ng/mL |
0.100 |
LC- MS/MS |
5 |
| |
| Simvastatin |
Simvastatin |
Human |
P |
0.0500- 50.0 ng/mL |
0.250 |
LC- MS/MS |
6 |
|
Simvastatin Acid |
Human |
P |
0.0500- 10.0 ng/mL |
0.250 |
LC- MS/MS |
6 |
| |
| Sulfasalazine |
Sulfasalazine |
Human |
P |
0.500- 20.0 µg/mL |
1.000 |
LC- MS/MS |
5 |
|
Sulfapyridine |
Human |
P |
0.500- 20.0 µg/mL |
1.000 |
LC- MS/MS |
5 |
| |
| Sulfasalazine |
Sulfasalazine |
Human |
P |
0.500- 50.0 µg/mL |
0.025 |
LC- MS/MS |
6 |
|
Sulfapyridine |
Human |
P |
0.500- 50.0 µg/mL |
0.025 |
LC- MS/MS |
6 |
|
5-Aminosalicylic Acid |
Human |
P |
0.0250- 2.50 µg/mL |
0.025 |
LC- MS/MS |
6 |
| |
| Testosterone |
Testosterone |
Human |
S |
20.0- 5,000 ng/dL |
0.500 |
LC- MS/MS |
N |
|
Dihydrotestosterone |
Human |
S |
5.00- 1,250 ng/dL |
0.500 |
LC- MS/MS |
N |
| |
| Venlafaxine |
Venlafaxine |
Human |
P |
1.00- 500 ng/mL |
0.050 |
LC- MS/MS |
6 |
|
Desmethyl Venlafaxine |
Human |
P |
1.00- 500 ng/mL |
0.050 |
LC- MS/MS |
6 |
| |
| Warfarin |
R-Warfarin |
Human |
P |
5.00- 1,500 ng/mL |
0.250 |
LC- MS/MS |
3 |
|
S-Warfarin |
Human |
P |
5.00- 1,500 ng/mL |
0.250 |
LC- MS/MS |
3 |
|